Literature DB >> 873640

Loss of specific natural cell-mediated cytotoxicity with absorption of natural antibodies from serum.

D Akira, M Takasugi.   

Abstract

When effector cells from most individuals are tested directly against a number of target cells for cell-mediated cytotoxicity, most of the reactivity is non-selective. This apparent non-selectiveness is a result of specific activity against multiple antigens on target cells by each effector suspension. The specific reactions can be demonstrated through competitive inhibition of natural cell-mediated cytotoxicity. The specific inhibition of cytotoxicity by competitor cells directed our attention toward the determination of specificity to the effector cell surface. Natural cell-mediated cytotoxicity was decreased when effector cells were treated with proteolytic enzymes or low pH and regained when these cells were incubated in serum, suggesting an antibody on cell surfaces of the effector cell. Reconstitution of trypsinized effector cells with absorbed serum resulted in selective loss of cytotoxicity against the absorbing cell. To determine the role of the effector cell and the role of antibodies in natural cell-mediated cytotoxicity, effector cells from two different persons were reconstituted in the same absorbed sera. The selective pattern achieved was similar. When effector cells from the same individual were reconstituted with two different sera absorbed in the same way, the selective pattern achieved showed greater differences. We concluded that natural antibodies loosely attached to effector cells provided the specificity of natural cell-mediated cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 873640     DOI: 10.1002/ijc.2910190603

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.

Authors:  I O Auer; E Ziemer; H Sommer
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

Review 2.  Natural killer cells: artifact to reality: an odyssey in biology.

Authors:  R K Oldham
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

3.  Spontaneous and lectin-dependent cellular cytotoxicity by lymphocyte subpopulations against cell lines susceptible or resistant to spontaneous cytotoxicity.

Authors:  M Jondal; S Targan
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

4.  The in vitro discrimination of rat immune and natural cytotoxicity by serum choice.

Authors:  V J Lindsay; R A Allardyce
Journal:  Immunology       Date:  1980-08       Impact factor: 7.397

5.  Spontaneous and antibody-dependent cell-mediated cytotoxicity by human T cell subpopulations.

Authors:  S Gupta; G Fernandes; M Nair; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Human spontaneous lymphocyte-mediated cytotoxicity (SLMC) against malignant and normal tissue-derived target cell lines tested in autologous and allogeneic combinations by the microcytotoxicity assay.

Authors:  M Vilien; M Troye-Blomberg; P Perlmann; H Wolf; F Rasmussen
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

7.  Immune status in Crohn's disease. 4. In vitro antibody dependent cell mediated cytotoxicity in peripheral blood.

Authors:  I O Auer; E Ziemer
Journal:  Klin Wochenschr       Date:  1980-08-01

8.  Natural killing and antibody-dependent cellular cytotoxicity are independent immune functions in the Minnesota miniature swine.

Authors:  H S Koren; D B Amos; Y B Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

9.  Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell.

Authors:  D Santoli; G Trinchieri; L Moretta; C M Zmijewski; H Koprowski
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

10.  Preliminary results on the use of the humoral immune response as a serum marker in patients with bladder tumors.

Authors:  U E Studer; J B deKernion; L Lovrekovich
Journal:  Urol Res       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.